MPP Strikes Long-Acting Injectable Cabotegravir Deal For HIV PrEP
Prospective Sub-Licensees Have Until 4 September To Submit Expressions Of Interest
• By David Wallace
The MPP has secured a license for long-acting injectable cabotegravir • Source: Shutterstock 
